Literature DB >> 15476685

Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects.

Lori L Altshuler1, Joseph Ventura, Wilfred G van Gorp, Michael F Green, David C Theberge, Jim Mintz.   

Abstract

BACKGROUND: Patients with bipolar disorder and schizophrenia have been shown to have neurocognitive deficits when compared with control subjects. The degree and pattern of impairment between psychiatric groups have rarely been compared, especially when subjects are psychiatrically stable.
METHODS: Using a standard neurocognitive battery, we compared euthymic outpatients with bipolar disorder (n = 40), stable patients with schizophrenia (n = 20), and subjects with no psychiatric disorder (n = 22). The neurocognitive domains assessed included executive functioning, verbal memory, visual memory, procedural learning, visuoconstructive ability, and language functions. Effect sizes were calculated for each cognitive domain across groups.
RESULTS: Stable schizophrenic subjects demonstrated a generalized cognitive impairment across most domains compared with control subjects, with average effect sizes of .9. Euthymic bipolar subjects were significantly impaired compared with control subjects only in executive functioning (Wisconsin Card Sorting Task) and verbal memory (California Verbal Learning Test) domains (effect sizes in the .8-.9 range). Performance on the executive function measures was bimodal among bipolar subjects, suggesting two subgroups: one with relatively normal and one with impaired executive functioning. No significant differences between the bipolar patient group and control subjects were observed in visuoconstructive ability, procedural learning, or language function.
CONCLUSIONS: Both euthymic bipolar subjects and relatively stable schizophrenic subjects differed from control subjects in neurocognitive function. Among schizophrenic subjects, a generalized cognitive impairment was observed, and the degree of impairment was greater in the schizophrenic compared with the bipolar subjects. Subjects with bipolar disorder were impaired in two specific domains (verbal memory and executive function). Furthermore, within the bipolar group there was a subset with relatively normal executive functioning and a subset with significant impairment. Possible reasons for the persistence of these neurocognitive deficits in some subjects with bipolar disorder during periods of euthymia are reviewed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15476685     DOI: 10.1016/j.biopsych.2004.08.002

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  68 in total

1.  Mindfulness-based cognitive therapy for nonremitted patients with bipolar disorder.

Authors:  Thilo Deckersbach; Britta K Hölzel; Lori R Eisner; Jonathan P Stange; Andrew D Peckham; Darin D Dougherty; Scott L Rauch; Sara Lazar; Andrew A Nierenberg
Journal:  CNS Neurosci Ther       Date:  2011-04-02       Impact factor: 5.243

Review 2.  Neurocognitive function as an endophenotype for genetic studies of bipolar affective disorder.

Authors:  Jonathan B Savitz; Mark Solms; Rajkumar S Ramesar
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

3.  Neurocognitive impairment in middle-aged and older adults with bipolar disorder: comparison to schizophrenia and normal comparison subjects.

Authors:  Colin A Depp; David J Moore; David Sitzer; Barton W Palmer; Lisa T Eyler; Scott Roesch; Barry D Lebowitz; Dilip V Jeste
Journal:  J Affect Disord       Date:  2007-01-16       Impact factor: 4.839

4.  Cortical gamma generators suggest abnormal auditory circuitry in early-onset psychosis.

Authors:  Tony W Wilson; Olivia O Hernandez; Ryan M Asherin; Peter D Teale; Martin L Reite; Donald C Rojas
Journal:  Cereb Cortex       Date:  2007-06-08       Impact factor: 5.357

5.  Three-dimensional mapping of hippocampal anatomy in adolescents with bipolar disorder.

Authors:  Carrie E Bearden; Jair C Soares; Andrea D Klunder; Mark Nicoletti; Nicole Dierschke; Kiralee M Hayashi; Katherine L Narr; Paolo Brambilla; Roberto B Sassi; David Axelson; Neal Ryan; Boris Birmaher; Paul M Thompson
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-05       Impact factor: 8.829

Review 6.  Endophenotypes in schizophrenia: a selective review.

Authors:  Allyssa J Allen; Mélina E Griss; Bradley S Folley; Keith A Hawkins; Godfrey D Pearlson
Journal:  Schizophr Res       Date:  2009-02-15       Impact factor: 4.939

Review 7.  The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm.

Authors:  Konstantinos N Fountoulakis; Lakshmi Yatham; Heinz Grunze; Eduard Vieta; Allan Young; Pierre Blier; Siegfried Kasper; Hans Jurgen Moeller
Journal:  Int J Neuropsychopharmacol       Date:  2017-02-01       Impact factor: 5.176

8.  Alterations in functional activation in euthymic bipolar disorder and schizophrenia during a working memory task.

Authors:  Liberty S Hamilton; Lori L Altshuler; Jennifer Townsend; Susan Y Bookheimer; Owen R Phillips; Jeffrey Fischer; Roger P Woods; John C Mazziotta; Arthur W Toga; Keith H Nuechterlein; Katherine L Narr
Journal:  Hum Brain Mapp       Date:  2009-12       Impact factor: 5.038

9.  Aberrant high-frequency desynchronization of cerebellar cortices in early-onset psychosis.

Authors:  Tony W Wilson; Erin Slason; Olivia O Hernandez; Ryan Asherin; Martin L Reite; Peter D Teale; Donald C Rojas
Journal:  Psychiatry Res       Date:  2009-09-23       Impact factor: 3.222

Review 10.  Deconstructing bipolar disorder: a critical review of its diagnostic validity and a proposal for DSM-V and ICD-11.

Authors:  Eduard Vieta; Mary L Phillips
Journal:  Schizophr Bull       Date:  2007-06-11       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.